Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate
Shandong Buchang Pharmaceuticals Co Ltd cash flow reinvestment rate. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow Reinvestment Rate of 0.57x as of June 2025, reinvesting CN¥160.85 Million (capex CN¥25.50 Million plus investments CN¥135.35 Million) from operating cash flow of CN¥280.95 Million. Explore how well can Shandong Buchang Pharmaceuticals Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Cash flow reinvestment rate of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. Historical reinvestment intensity for Shandong Buchang Pharmaceuticals Co Ltd across 13 annual periods. Explore capital reinvestment ratio of Shandong Buchang Pharmaceuticals Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2011–2024)
Shandong Buchang Pharmaceuticals Co Ltd cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for Shandong Buchang Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Shandong Buchang Pharmaceuticals Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥257.58 Million | CN¥939.95 Million | CN¥197.00 Million | ▼ -26.1% |
| 2022 | 0.37x | CN¥1.02 Billion | CN¥2.76 Billion | CN¥543.17 Million | ▲ +1.9% |
| 2021 | 0.36x | CN¥480.44 Million | CN¥1.32 Billion | CN¥433.53 Million | ▲ +26.1% |
| 2020 | 0.29x | CN¥564.95 Million | CN¥1.96 Billion | CN¥536.44 Million | ▲ +12.2% |
| 2019 | 0.26x | CN¥674.04 Million | CN¥2.62 Billion | CN¥662.11 Million | ▼ -68.8% |
| 2018 | 0.83x | CN¥1.69 Billion | CN¥2.05 Billion | CN¥1.31 Billion | ▼ -3.9% |
| 2017 | 0.86x | CN¥1.68 Billion | CN¥1.96 Billion | CN¥1.46 Billion | ▲ +11.3% |
| 2016 | 0.77x | CN¥1.29 Billion | CN¥1.67 Billion | CN¥677.87 Million | ▲ +240.0% |
| 2015 | 0.23x | CN¥480.78 Million | CN¥2.12 Billion | CN¥480.78 Million | ▲ +97.0% |
| 2014 | 0.12x | CN¥204.88 Million | CN¥1.78 Billion | CN¥204.88 Million | ▼ -74.9% |
| 2013 | 0.46x | CN¥510.85 Million | CN¥1.11 Billion | CN¥510.85 Million | ▲ +13.9% |
| 2012 | 0.40x | CN¥543.34 Million | CN¥1.35 Billion | CN¥543.34 Million | ▲ +64.9% |
| 2011 | 0.24x | CN¥378.91 Million | CN¥1.55 Billion | CN¥378.91 Million | — |